Roche Provides Reach For Millennium Rheumatoid Arthritis Test
This article was originally published in The Gray Sheet
Executive Summary
Millennium Pharmaceuticals' three-year partnership with Roche Diagnostics to develop proteomics-based diagnostic products for rheumatoid arthritis complements the firm's existing alliance with Aventis to jointly commercialize therapeutic products for the disease.
You may also be interested in...
Abbott/Millennium Alliance Includes Focus On Obesity, Diabetes Markets
Abbott Laboratories' $250 mil. joint development alliance with Millennium Pharmaceuticals for obesity and diabetes diagnostics and therapeutics will leverage Millennium's genomics expertise and is directed at products in the metabolic disease area.
Abbott/Millennium Alliance Includes Focus On Obesity, Diabetes Markets
Abbott Laboratories' $250 mil. joint development alliance with Millennium Pharmaceuticals for obesity and diabetes diagnostics and therapeutics will leverage Millennium's genomics expertise and is directed at products in the metabolic disease area.
Roche, DeCode Genetics Expand Alliance To Focus On DNA-Based Diagnostics
Roche Diagnostics' five-year agreement with DeCode Genetics to develop DNA-based diagnostic products builds on the firms' 1998 gene discovery alliance targeting 12 disease states, including adult onset diabetes and schizophrenia.